Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Linker histone H1 variants are a family of essential proteins that facilitate the organization of higher-order chromatin structure by binding to the linker DNA between nucleosomes. These variants, including H1.0 through H1.5 and H1x, are critical for stabilizing the 30-nm fiber and regulating the accessibility of specific chromatin loci to the transcriptional machinery (UniProt, 2024). Beyond their structural role, H1 variants function as dynamic regulators of gene expression, DNA repair, and cell differentiation, with specific variants often localizing to distinct genomic regions such as heterochromatin or active promoters (PubMed: 29107537). In various diseases, particularly cancer, the expression patterns of H1 variants are frequently altered, contributing to epigenetic reprogramming and tumor progression (PubMed: 30554877). For example, H1.0 is often downregulated in undifferentiated cancer cells, while specific mutations in H1.4 are associated with Rahman syndrome, a neurodevelopmental disorder (NIH, 2023). Therapeutic strategies targeting H1 variants involve small molecules that disrupt H1-DNA binding or modulate post-translational modifications, though achieving variant-specific targeting remains a significant challenge due to the high conservation and ubiquitous nature of these proteins (PubMed: 34206055).
Modulation of chromatin accessibility and higher-order structure through the displacement or stabilization of linker histones at specific genomic loci to alter gene expression and DNA damage responses.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Linker histone H1 family and associated chromatin loci (H1).